Hodgkin's Lymphoma Treatment

The main types of treatment for Hodgkin's lymphoma are:

Chemotherapy
Chemotherapy is the use of drugs to kill cancer cells and shrink tumors. Chemotherapy for Hodgkin's is described in detail on the Hodgkin's Chemotherapy Page.
Bone marrow and peripheral blood transplants
Bone marrow transplantation (BMT) and peripheral blood stem cell transplantation (PBSCT) are the use of high doses of chemotherapy with a rescue of the immune system afterwards. More on the Transplantation Information Page.
Immunotherapy
Immunotherapy is being studied in Hodgkin's treatment including monoclonal antibody therapy (such as rituxan) and vaccine therapy may not be far off.
Radiation therapy
Radiation for Hodgkin's treatment usually comes from a machine outside the body (external beam radiation therapy). Radiation therapy given to the neck, chest, and lymph nodes under the arms is called radiation therapy to the mantle field. Radiation therapy given to the mantle field and to the lymph nodes in the upper abdomen, the spleen, and the lymph nodes in the pelvis is called total nodal irradiation. Radiation therapy may be used alone or in addition to chemotherapy. Radiation has been used in early stage disease or in later stages directed at bulky disease (areas where there are large tumors). With the effectiveness of current chemotherapy, radiotherapy may be limited to unresponsive disease or very localized disease. Current medical literature should be examined and talk to your medical team.

Clinical trials

Clinical trials are often used for people who are not responsive to conventional treatment or who wish to help researchers test new therapies. New therapies may include variations on chemotherapy drug combinations or the addition of immunotherapy for example.

Combination therapy

Several types of therapy may be combined - for example immunotherapy is being studied in conjunction with traditional chemotherapy drugs to make them work better. Likewise, depending on disease presentation, radiotherapy may be added to chemotherapy.

Pretreatment Testing

Prior to treatment, the doctors may perform additional tests to measure such things as heart function (MUGA) and pulmonary (lung) function (Pulmonary Function Test). This sets a baseline to determine if lung or heart function is impacted by the treatment.

To learn more about pretreatment testing, see:

Related Reading

Online Resources

More Articles

More Articles

In T cell lymphoma, T lymphocytes, which are an essential part of the body's immune response, become malignant. T cell lymphomas account for about...

Lymphomatoid Papulosis (LyP) is a rare skin disorder that involves cancerous looking skin lesions. It is more than a skin condition; it is the...

In non-Hodgkin's lymphoma, you have your B-cell lymphomas and you have your T-cell lymphomas.

Why B...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is a relatively rare B-cell subtype of non-Hodgkin'...

T-Cell Lymphoblastic Lymphoma (T-LBL) is a very rare subtype of non-Hodgkin's lymphoma. It tends to develop in...

In general, a diagnosis of T-cell lymphoma denotes a poorer prognosis than a diagnosis of B-cell lymphoma. One of...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...